GlobeNewswire

Årsstämma i Oasmia Pharmaceutical AB den 26 september 2019

Dela


Oasmia Pharmaceutical AB (publ) höll under torsdagen den 26 september 2019 årsstämma varvid beslutades bl.a. vad som sammanfattas i det följande. Stämman beslutade att fastställa resultaträkningen och balansräkningen samt koncernresultaträkningen och koncernbalansräkningen för räkenskapsåret 2018/2019.

Stämman beslutade, i enlighet med styrelsens förslag, att ingen utdelning ska ske samt att överkursfonden 1 479 826 299 kronor, balanserat resultat minus 936 258 117 kronor samt årets resultat minus 157 987 515 kronor, totalt 385 580 667 kronor, ska överföras i ny räkning.

Stämman beslutade att bevilja nuvarande styrelseledamöterna, valda vid den extra bolagsstämman den 19 mars 2019 och den tidigare verkställande direktören ansvarsfrihet gentemot bolaget för förvaltningen för den tid årsredovisningen omfattade. Stämman beslutade om att inte bevilja ansvarsfrihet för den tidigare styrelsen.

Stämman beslutade, i enlighet med valberedningens förslag, att antalet styrelseledamöter  ska vara sex, utan suppleanter.
Stämman beslutade, i enlighet med valberedningens förslag, om nyval av Hege Hellström och Anders Härfstrand till nya styrelseledamöter samt omval av de nuvarande styrelseledamöterna Jörgen Olsson, Peter Zonabend, Gunilla Öhman och Sven Rohmann. Jörgen Olsson omvaldes som styrelsens ordförande.

Stämman beslutade i enlighet med styrelsens förslag att gränserna i bolagsordningens § 4 om aktiekapital och antal aktier ändras till följande lydelse: ”Aktiekapitalet skall utgöra lägst 24 000 000 kronor och högst 96 000 000 kronor. Antalet aktier skall vara lägst 240 000 000 st och högst 960 000 000 st”.

Bolagsstämman fattade beslut, enligt styrelsens förslag, om emissionsbemyndigande om maximalt 62 miljoner aktier.

För mer information:
Urban Ekelund, IR-chef Oasmia
E-post: IR@oasmia.com

Om Oasmia Pharmaceutical AB
(NASDAQ Stockholm: OASM) Oasmia Pharmaceutical AB utvecklar, tillverkar, marknadsför och säljer en ny generation av läkemedel inom human- och veterinär onkologi. Produktutvecklingen syftar till att framställa nya formuleringar innehållande nanopartiklar av väletablerade cytostatika som i jämförelse med befintliga alternativ har förbättrande egenskaper, förbättrad biverkningsprofil samt bredare användningsområden. Produktutvecklingen bygger på egen forskning inom nanoteknik och egna patent. Bolagets aktie är noterad på NASDAQ i Stockholm och Frankfurt Stock Exchange.

Bilaga

Om

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Följ GlobeNewswire

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från GlobeNewswire

Cypress Development Files Prefeasibility Study for Clayton Valley Lithium Project in Nevada3.6.2020 21:13:48 CESTPress release

VANCOUVER, British Columbia, June 03, 2020 (GLOBE NEWSWIRE) -- Cypress Development Corp. (TSX-V:CYP) (OTCQB:CYDVF) (Frankfurt:C1Z1) (“Cypress” or “the Company”) is pleased to announce, further to its News Release on May 19, 2020, the full Prefeasibility Study (PFS) of the Clayton Valley Lithium Project in Nevada, U.S.A. was filed on SEDAR and is available on the Company’s web site. The PFS was prepared by Continental Metallurgical Services (CMS) and Global Resource Engineering (GRE) and has an Effective Date of May 19, 2020. Todd Fayram (CMS), Terre Lane (GRE), and Daniel Kalmbach are the authors. Highlights from the PFS and news release are as follows: Average production rate of 15,000 tonnes per day to produce 27,400 tonnes lithium carbonate equivalent (LCE) annually over a +40-year mine life. Capital cost estimate of US$493 million, pre-production, and operating cost estimate averaging US$3,329* per tonne LCE. (* see Note) After-tax net present value at an 8% discount rate (NPV-8%)

Cleantech Building Materials: Notice of AGM3.6.2020 18:55:17 CESTPress release

3 June 2020 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN TICKER: CBM CLEANTECH BUILDING MATERIALS PLC Notice of AGM Cleantech Building Materials plc ("CBM" or the "Company") confirms that the Annual General Meeting will be held on 26 June 2020 at 11.00am at 19 Colville Mews, London, W11 2DA. Copies of the following documents have today been posted to the Company’s shareholders: 1. Circular to shareholders of the Company, including notice of the Annual General Meeting of the Company; 2. Form of proxy for use at the Annual General Meeting; and 3. Annual Results of the Company for the year ended 31 December 2019. A copy of the Circular and the Form of Proxy are attached to this release. Further information including the Circular, the Form of Proxy and the Annual Results may be found at the Company's website at www.cbm-plc.com COVID-19 – AGM Arrangements Due to the ongoing UK Government "stay at home measures" which currently include a prevention of public

Arion Bank: Covered bond offering results3.6.2020 18:53:06 CESTPress release

Today Arion Bank hf. concluded the sale of two covered bond series. In total, 24 bids were received in the auction for the amount of ISK 2,980 million. The inflation-linked series ARION CBI 26 attracted 17 bids of ISK 2,400 million at a yield of 0.62-0.70%. Bids for nominal amount of ISK 1,000 million at a yield of 0.65% were accepted. The size of the series following the issuance will be ISK 17,080 m. The fixed rate series ARION CB 24 attracted 7 bids of ISK 580 million at a yield of 2.54–2.58%. All bids were rejected at this time. The issued bonds are scheduled to be admitted to trading on Nasdaq Iceland on 10 June 2020. For further information please contact Investor relations, at ir@arionbanki.is

Medtronic CEO Geoff Martha to Speak at Goldman Sachs Global Healthcare Conference3.6.2020 17:00:10 CESTPress release

DUBLIN, June 03, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the Goldman Sachs 41st Annual Global Healthcare Conference, held virtually on Tuesday, June 9, 2020. Geoff Martha, Medtronic chief executive officer, will answer questions about the company beginning at 8:00 a.m. EDT (7:00 a.m. CDT). A live audio webcast of the session will be available on June 9, 2020, by clicking on the Investor Events link at http://investorrelations.medtronic.com, and an archive of the session will be available on the same webpage later in the day. About Medtronic Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than

Resolutions by Vaisala Corporation Annual General Meeting and the Board of Directors3.6.2020 16:30:00 CESTPress release

Vaisala Corporation Stock exchange release June 3, 2020 at 5:30 p.m. (EEST) Resolutions by Vaisala Corporation Annual General Meeting and the Board of Directors Vaisala Corporation’s Annual General Meeting was held on June 3, 2020. The meeting approved the financial statements and discharged the members of the Board of Directors and the President and CEO from liability for the financial period January 1–December 31, 2019. Dividend The Annual General Meeting decided a dividend of EUR 0.61 per share. The record date for the dividend payment is June 5, 2020, and the payment date is June 12, 2020. Board of Directors The Annual General Meeting confirmed that the number of Board members is eight. Petri Castrén, Petra Lundström, Jukka Rinnevaara, Kaarina Ståhlberg, Tuomas Syrjänen, Raimo Voipio and Ville Voipio will continue as members of the Board of Directors. Antti Jääskeläinen was elected as a new member of the Board of Directors. The Annual General Meeting confirmed that that the annual

SEK TENDER OPERATION ANNOUNCEMENT FOR ONWARD LENDING3.6.2020 16:20:00 CESTPress release

SEK TENDER OPERATION ANNOUNCEMENT FOR ONWARD LENDING 2020-06-05 Transaction type:SEK CreditTender date:2020-06-05Time for submission of bids:10.00-10.30 (CEST)Payment date:2020-06-09Final repayment date2022-06-09Offered volume:50 bn SEKMinimum bid amount:10 mln SEKMaximum bid amount:12.5 bn SEKMaximum number of bids from each participant: 1Interest rate:0.00 %Supplemental interest rate 0.20 percentage points ALL APPROVED COUNTERPARTIES ARE INVITED TO SUBMIT VOLUME BIDS TO THE RIKSBANK (46-8-6966970) BY 10.30 ON JUNE 5 2020, AT THE LATEST. Result of the auction will be published at 11.00 (CEST) on Tender date. Complete terms and conditions can be retrieved at http://www.riksbank.se